Biosyntia ApS
Private limited companyCVR 34892970København ØActive
Biosyntia ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2012. The company made a loss in both 2024 and 2025, most recently DKK 20.1m. Equity fell to DKK 32.9m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 18.9m to DKK 20.1m (2024 → 2025).
- Equity fell 38% (2024 → 2025), to DKK 32.9m.
Employees
- 1 fewer employees than a year earlier: 12 (07/2026) against 13 (07/2025).
Management and owners, last 24 months
- Stepped down: Søren Knud Carlsen (board member, 31/12/2024), Michael Jean Nettersheim (board member, 31/08/2026) and Sara Sande (board member, 08/09/2026).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 818 | 1,167 | −16,583 | −17,798 | −14,052 | −14,223 | −1.2% |
| Operating profit (EBIT) | – | −11,979 | −32,422 | −34,406 | −25,094 | −24,858 | +0.9% |
| Profit before tax | −11,972 | −12,672 | −33,297 | −33,568 | −24,409 | −24,926 | −2.1% |
| Net profit | −9,352 | −10,062 | −26,435 | −29,430 | −18,909 | −20,066 | −6.1% |
| Total assets | 31,292 | 34,290 | 122,006 | 92,459 | 69,170 | 44,294 | −36% |
| Equity | 26,213 | 16,150 | 101,266 | 71,836 | 52,927 | 32,861 | −37.9% |
| Liabilities | 5,079 | 18,140 | 20,739 | 20,623 | 16,243 | 11,434 | −29.6% |
| Cash and cash equivalents | 19,892 | 5,278 | 109,970 | 84,170 | 60,812 | 38,154 | −37.3% |
| Average number of employees | 21 | 17 | 19 | 19 | 12 | 12 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 38% from 2024 to 2025 (DKK 52.9m to DKK 32.9m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 08/07/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 24/04/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 17/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 19/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 28/04/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 15/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,681of 69,742 Better than 0% | No. 4,185of 69,964 Better than 94% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 315of 323 Better than 2% | No. 22of 329 Better than 94% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,534of 33,588 Better than 0% | No. 1,642of 33,687 Better than 95% |
| All companies of type ApS66,508 companies in the comparison | No. 66,320of 66,379 Better than 0% | No. 2,944of 66,505 Better than 96% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Biosyntia ApS−DKK 14.2m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Biosyntia ApS−DKK 20.1m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Biosyntia ApSDKK 32.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Biosyntia ApS12
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Holdings A/S33.33%
- Sofinnova Industrial Biotech I25%
- Ecbf i Scsp10%
- Praesidium S.C.A. SICAV-RAIF5%
- Danmarks Eksport- og Investeringsfond10%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Martin Plambech | CEO | 15/07/2017 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Henrik Dalbøge | Chair of the board | 13/05/2014 |
| Joško Bobanović | Board member | 24/04/2018 |
| Thomas Grotkjær | Board member | 06/12/2019 |
- Founders
- Cajaikas ApS, Genee ApS
Former management (9)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Morten Otto Alexander Sommer | Director | 19/12/2012 | 13/05/2014 |
| Hans Jasper Genee | Board member | 13/05/2014 | 07/05/2015 |
| Hans Jasper Genee | CEO | 13/05/2014 | 07/05/2015 |
| Morten Otto Alexander Sommer | Board member | 13/05/2014 | 20/06/2022 |
| Søren Knud Carlsen | Board member | 07/05/2015 | 31/12/2024 |
| Søren Møller | Board member | 07/05/2015 | 06/12/2019 |
| Morten Otto Alexander Sommer | CEO | 07/05/2015 | 15/07/2017 |
| Michael Jean Nettersheim | Board member | 20/06/2022 | 31/08/2026 |
| Sara Sande | Board member | 30/09/2022 | 08/09/2026 |
Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening, hvoraf den ene skal være formanden, af den samlede bestyrelse, eller af formanden i forening med en direktør.
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
- River Stone Biotech ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| BIOSYNTIA ApS | Fruebjergvej 3, 2100 København Ø | 9 | 1018150073 |
Purpose
Selskabets formål er at drive forskning, udvikling og produktion af biobaserede kemikalier.
The purpose is quoted from the register in Danish.
Changes year by year
73 registered events20263 changesmanagement 2 · accounts 1
- ManagementSara Sande stepped down as board member
- ManagementMichael Jean Nettersheim stepped down as board member
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20243 changesmanagement 1 · accounts 1 · industry 1
- ManagementSøren Knud Carlsen stepped down as board member
- AccountsAnnual report for 2023 published
- IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20233 changesaccounts 1 · ownership 2
- AccountsAnnual report for 2022 published
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
- OwnershipVÆKSTFONDEN is no longer registered as owner
202219 changescapital 2 · management 3 · ownership 13 · accounts 1
- CapitalShare capital changed from 635,656 DKK to 801,859 DKK
- ManagementSara Sande appointed board member
- OwnershipVÆKSTFONDEN registered as owner (10%)
- OwnershipPraesidium S.C.A. SICAV-RAIF registered as owner (5%)
- OwnershipCAJAIKAS ApS is no longer registered as owner
- OwnershipGENEE ApS is no longer registered as owner
- CapitalShare capital changed from 287,146 DKK to 635,656 DKK
- ManagementMichael Jean Nettersheim appointed board member
- ManagementMorten Otto Alexander Sommer stepped down as board member
- OwnershipNovo Holdings A/S registered as owner (33.33%)
- OwnershipCAJAIKAS ApS registered as owner (5%)
- OwnershipGENEE ApS registered as owner (5%)
- OwnershipECBF I SCSp registered as owner (10%)
- OwnershipSofinnova Industrial Biotech I registered as owner (25%)
- OwnershipGENEE ApS is no longer registered as owner
- OwnershipCAJAIKAS ApS is no longer registered as owner
- OwnershipSofinnova Industrial Biotech I is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20192 changesmanagement 2
- ManagementThomas Grotkjær appointed board member
- ManagementSøren Møller stepped down as board member
201814 changescapital 2 · ownership 11 · management 1
- CapitalShare capital changed from 217,888 DKK to 287,146 DKK
- OwnershipGENEE ApS registered as owner (10%)
- OwnershipCAJAIKAS ApS registered as owner (10%)
- OwnershipSofinnova Industrial Biotech I registered as owner (20%)
- OwnershipCAJAIKAS ApS is no longer registered as owner
- OwnershipSofinnova Industrial Biotech I is no longer registered as owner
- OwnershipGENEE ApS is no longer registered as owner
- CapitalShare capital changed from 148,630 DKK to 217,888 DKK
- ManagementJoško Bobanović appointed board member
- OwnershipCAJAIKAS ApS registered as owner (15%)
- OwnershipSofinnova Industrial Biotech I registered as owner (15%)
- OwnershipGENEE ApS registered as owner (15%)
- OwnershipGENEE ApS is no longer registered as owner
- OwnershipCAJAIKAS ApS is no longer registered as owner
20172 changesmanagement 2
- ManagementMartin Plambech appointed ceo
- ManagementMorten Otto Alexander Sommer stepped down as ceo
20168 changesaddress 1 · capital 1 · ownership 6
- AddressMoved to Fruebjergvej 3, 2100 København Ø
- CapitalShare capital changed from 109,333 DKK to 148,630 DKK
- OwnershipGENEE ApS registered as owner (20%)
- OwnershipCAJAIKAS ApS registered as owner (20%)
- OwnershipNovo Holdings A/S registered as owner (33.33%)
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipCAJAIKAS ApS is no longer registered as owner
- OwnershipGENEE ApS is no longer registered as owner
20157 changescapital 1 · management 5 · ownership 1
- CapitalShare capital changed from 80,000 DKK to 109,333 DKK
- ManagementMorten Otto Alexander Sommer appointed ceo
- ManagementSøren Knud Carlsen appointed board member
- ManagementSøren Møller appointed board member
- ManagementHans Jasper Genee stepped down as ceo
- ManagementHans Jasper Genee stepped down as board member
- OwnershipNovo Holdings A/S registered as owner (25%)
20145 changesmanagement 5
- ManagementHenrik Dalbøge appointed chair of the board
- ManagementMorten Otto Alexander Sommer appointed board member
- ManagementHans Jasper Genee appointed ceo
- ManagementHans Jasper Genee appointed board member
- ManagementMorten Otto Alexander Sommer stepped down as director
20124 changesfounded 1 · management 1 · ownership 2
- FoundedRegistered as BIOSYNTIA ApS
- ManagementMorten Otto Alexander Sommer appointed director
- OwnershipCAJAIKAS ApS registered as owner (33.33%)
- OwnershipGENEE ApS registered as owner (33.33%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Novozymes A/Svia Morten Otto Alexander Sommer
- Chr. Hansen A/Svia Henrik Dalbøge
- Servier Symphogen A/Svia Søren Knud Carlsen
- Monta ApSvia Sara Sande
- Bioneer A/Svia Søren Knud Carlsen
- Matr Foods ApSvia Thomas Grotkjær
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.